Answers are grounded in this paper and cite their sources.
: Bleeding in cardiac surgery carries a high mortality and is more frequent in case of coagulopathy. Goal-directed hemostatic therapy is widely accepted to be associated with reduced bleeding volume and allogeneic blood transfusion requirements, possibly thereby improving outcomes in cardiac surgery. We performed a prospective, single-center, observational study investigating the analytical accuracy and feasibility of the coagulation device “CoaguCheck” (COGC) for point-of-care monitoring of blood coagulation profiles in the operating room in patients undergoing on-pump cardiovascular surgery. With ethical committee approval, 31 consecutive patients were recruited for the study. At 3 operative-time-points before and after cardiopulmonary bypass (CPB), international normalized ratio of prothrombin time (PT-INR) and activated partial thromboplastin time (APTT) were measured in parallel using the COGC and central laboratory tests, which served as reference standards. The bias and dispersion of the two assays were calculated to assess systematic error and random error, respectively. For PT-INR, the COGC showed acceptable to good results in terms of accuracy and feasibility. However, the Bland-Altman analysis revealed that the COGC tended to overestimate APTT values, particularly after CPB. Among patients undergoing on-pump cardiovascular surgery, the COGC is a feasible and relatively accurate analyzer for assessing PT-INR but not APTT values.
No takes yet. Share an insight, caveat, or question.
Kamei et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: